Skip to content
Tango Therapeutics Inc icon

Tango Therapeutics Inc

TNGXStocksBiotechnologyUnited StatesNasdaqUSD

Price

$21.88

Today

-5.1%

YTD

+147.3%

About

Tango Therapeutics, Inc. is a biopharmaceutical company that specialises in developing precision medicines to improve patient outcomes in cancer. Its operation primarily covers the United States, focusing on leveraging the body's immune system to combat disease. The company is part of the biotechnology industry, known for its advancements in medical solutions. Tango Therapeutics, Inc. aims to deliver the next generation of precision medicine for the treatment of cancer by targeting genetic vulnerabilities in cancer cells and using its proprietary suite of drug discovery tools to find unique therapeutic opportunities. Diversify your virtual portfolio by following TNGX shares on eToro.

Price chart
Closing price history for TNGX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-27.55
P/S (TTM)64.28
P/B (TTM)3.79
Market cap$3.89B
Cap tierMid-cap
Industry avg P/E-1.91

Profitability

Gross margin96.43%
EBIT margin-253.38%
Net margin29.52%
ROE-21.34%
ROA-18.86%

Earnings & Revenue

Revenue (TTM)$53.81M
Revenue growth (1Y)+121.5%
EPS (TTM)-$0.84
Free cash flow$-144.27M
Total debt$31.99M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.25
Employees137
Next earnings4 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Tango Therapeutics Inc (TNGX) | Dirk Kuyken